Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GraniteShares Gold Trust stock logo
BAR
GraniteShares Gold Trust
$37.91
-0.7%
$40.78
$37.80
▼
$54.63
$1.25B0.2555,578 shs284,510 shs
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
$335.29
-0.8%
$312.13
$146.20
▼
$379.63
$16.33B1.361.29 million shs693,585 shs
Revelation Biosciences, Inc. stock logo
REVB
Revelation Biosciences
$3.73
-12.5%
$5.09
$3.08
▼
$40.60
$2.99M-0.1327,757 shs8,466 shs
The Beauty Health Company stock logo
SKIN
Beauty Health
$15.05
-7.7%
$12.58
$9.68
▼
$33.00
$103.85M1.0575,348 shs73,146 shs
The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GraniteShares Gold Trust stock logo
BAR
GraniteShares Gold Trust
0.00%-4.55%-6.92%-12.21%-5.19%
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
0.00%+0.11%+12.63%+18.09%+101.78%
Revelation Biosciences, Inc. stock logo
REVB
Revelation Biosciences
0.00%+11.39%+27.71%-46.17%-82.79%
The Beauty Health Company stock logo
SKIN
Beauty Health
0.00%+3.82%+54.45%+35.92%-36.29%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GraniteShares Gold Trust stock logo
BAR
GraniteShares Gold Trust
$37.91
-0.7%
$40.78
$37.80
▼
$54.63
$1.25B0.2555,578 shs284,510 shs
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
$335.29
-0.8%
$312.13
$146.20
▼
$379.63
$16.33B1.361.29 million shs693,585 shs
Revelation Biosciences, Inc. stock logo
REVB
Revelation Biosciences
$3.73
-12.5%
$5.09
$3.08
▼
$40.60
$2.99M-0.1327,757 shs8,466 shs
The Beauty Health Company stock logo
SKIN
Beauty Health
$15.05
-7.7%
$12.58
$9.68
▼
$33.00
$103.85M1.0575,348 shs73,146 shs
The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GraniteShares Gold Trust stock logo
BAR
GraniteShares Gold Trust
0.00%-4.55%-6.92%-12.21%-5.19%
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
0.00%+0.11%+12.63%+18.09%+101.78%
Revelation Biosciences, Inc. stock logo
REVB
Revelation Biosciences
0.00%+11.39%+27.71%-46.17%-82.79%
The Beauty Health Company stock logo
SKIN
Beauty Health
0.00%+3.82%+54.45%+35.92%-36.29%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
GraniteShares Gold Trust stock logo
BAR
GraniteShares Gold Trust
0.00
N/AN/AN/A
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
2.71
Moderate Buy$311.67-7.05% Downside
Revelation Biosciences, Inc. stock logo
REVB
Revelation Biosciences
1.00
SellN/AN/A
The Beauty Health Company stock logo
SKIN
Beauty Health
2.00
Hold$16.6710.74% Upside

Current Analyst Ratings Breakdown

Latest CRL, REVB, SKIN, and BAR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/11/2026
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
Reiterated RatingBuy$388.00
11/10/2026
Revelation Biosciences, Inc. stock logo
REVB
Revelation Biosciences
UpgradeSell (E) ➝ Sell (E+)
11/9/2026
The Beauty Health Company stock logo
SKIN
Beauty Health
Set Price Target$14.00
11/9/2026
The Beauty Health Company stock logo
SKIN
Beauty Health
Reiterated RatingHold$0.90 ➝ $14.00
11/5/2026
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
Boost Price TargetBuy$357.00 ➝ $387.00
11/5/2026
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
Boost Price TargetOutperform$322.00 ➝ $352.00
11/5/2026
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
Boost Price TargetOverweight$330.00 ➝ $375.00
11/2/2026
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
DowngradeStrong-Buy ➝ Hold
10/30/2026
The Beauty Health Company stock logo
SKIN
Beauty Health
Initiated CoverageHold
10/22/2026
The Beauty Health Company stock logo
SKIN
Beauty Health
Set Price TargetHold$1.00 ➝ $11.00
10/21/2026
The Beauty Health Company stock logo
SKIN
Beauty Health
Reiterated RatingSell (E+)
(Data available from 11/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
GraniteShares Gold Trust stock logo
BAR
GraniteShares Gold Trust
N/AN/AN/AN/AN/AN/A
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
$4.02B4.00$21.59 per share15.53$67.45 per share4.97
Revelation Biosciences, Inc. stock logo
REVB
Revelation Biosciences
N/AN/AN/AN/A$10.59 per shareN/A
The Beauty Health Company stock logo
SKIN
Beauty Health
$300.80M0.33$2.88 per share5.22$8.57 per share1.76
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
GraniteShares Gold Trust stock logo
BAR
GraniteShares Gold Trust
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
-$144.34M$0.91368.4526.153.081.01%16.95%6.93%N/A
Revelation Biosciences, Inc. stock logo
REVB
Revelation Biosciences
-$8.91M-$42.52N/AN/AN/AN/A-124.23%-98.96%N/A
The Beauty Health Company stock logo
SKIN
Beauty Health
-$9.52M-$2.74N/AN/AN/A-6.34%-32.16%-3.96%N/A

Latest CRL, REVB, SKIN, and BAR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/5/2026Q3 2026
Revelation Biosciences, Inc. stock logo
REVB
Revelation Biosciences
-$6.16-$5.92+$0.24-$5.92N/AN/A
11/5/2026Q3 2026
The Beauty Health Company stock logo
SKIN
Beauty Health
-$1.33-$0.14+$1.19-$0.14$67.97 million$69.17 million
11/4/2026Q3 2026
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
$2.97$3.09+$0.12$6.86$960.36 million$982.73 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
GraniteShares Gold Trust stock logo
BAR
GraniteShares Gold Trust
N/A0.00%N/AN/AN/A
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
N/AN/AN/AN/AN/A
Revelation Biosciences, Inc. stock logo
REVB
Revelation Biosciences
N/AN/AN/AN/AN/A
The Beauty Health Company stock logo
SKIN
Beauty Health
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
GraniteShares Gold Trust stock logo
BAR
GraniteShares Gold Trust
N/AN/AN/A
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
0.76
1.41
1.12
Revelation Biosciences, Inc. stock logo
REVB
Revelation Biosciences
N/A
3.98
6.22
The Beauty Health Company stock logo
SKIN
Beauty Health
4.36
2.89
1.48
CompanyEmployeesShares OutstandingFree FloatOptionable
GraniteShares Gold Trust stock logo
BAR
GraniteShares Gold Trust
2,02133.05 millionN/ANot Optionable
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
19,70047.92 million47.29 millionOptionable
Revelation Biosciences, Inc. stock logo
REVB
Revelation Biosciences
9680,000650,000Not Optionable
The Beauty Health Company stock logo
SKIN
Beauty Health
6136.51 million4.22 millionOptionable

Recent News About These Companies

Reviewing Beauty Health (SKIN) and Its Competitors
Beauty Health Q3 Earnings Call Highlights
4 beauty trends that are clogging your pores

New MarketBeat Followers Over Time

Media Sentiment Over Time

GraniteShares Gold Trust stock logo

GraniteShares Gold Trust NYSEARCA:BAR

$37.91 -0.27 (-0.71%)
Closing price 04:10 PM Eastern
Extended Trading
$37.96 +0.05 (+0.13%)
As of 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

The GraniteShares Gold Trust (BAR) is an exchange-traded fund that is based on the LBMA Gold Price index. The fund tracks the gold spot price, less trust expenses and liabilities, using physically held gold stored and secured in vaults in London. BAR was launched on Aug 31, 2017 and is managed by GraniteShares.

Charles River Laboratories International stock logo

Charles River Laboratories International NYSE:CRL

$335.29 -2.68 (-0.79%)
Closing price 03:59 PM Eastern
Extended Trading
$331.00 -4.29 (-1.28%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It also provides contract vivarium operation services to biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Revelation Biosciences stock logo

Revelation Biosciences NASDAQ:REVB

$3.73 -0.53 (-12.51%)
Closing price 03:58 PM Eastern
Extended Trading
$3.72 0.00 (-0.05%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-SSI, a potential therapy for the prevention and treatment of surgical sit infection; GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was founded in 2020 and is based in San Diego, California.

Beauty Health stock logo

Beauty Health NASDAQ:SKIN

$15.05 -1.26 (-7.73%)
Closing price 04:00 PM Eastern
Extended Trading
$15.03 -0.02 (-0.13%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.